šošovka kontaktná proclear multifocal toric
cooper vision manufacturing limited south point so31 4rf hamble, southampton spojené kráľovstvo veľkej británie a severného Írska -
šošovka kontaktná proclear multifocal xr
cooper vision manufacturing limited south point so31 4rf hamble, southampton spojené kráľovstvo veľkej británie a severného Írska -
šošovka kontaktná proclear toric
cooper vision manufacturing limited south point so31 4rf hamble, southampton spojené kráľovstvo veľkej británie a severného Írska -
šošovka kontaktná proclear toric xr
cooper vision manufacturing limited south point so31 4rf hamble, southampton spojené kráľovstvo veľkej británie a severného Írska -
šošovka kontaktná proclear, switch comfort
cooper vision manufacturing limited south point so31 4rf hamble, southampton spojené kráľovstvo veľkej británie a severného Írska -
šošovka kontaktná misight
cooper vision manufacturing limited south point so31 4rf hamble, southampton spojené kráľovstvo veľkej británie a severného Írska -
šošovka kontaktná myday multifocal, medivue more multifocal, options supreme 1 day multifocal, ultraflex opti 1 day multifocal,
cooper vision manufacturing limited south point so31 4rf hamble, southampton spojené kráľovstvo veľkej británie a severného Írska -
comirnaty
biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vakcíny - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. použitie tejto vakcíny by mali byť v súlade s oficiálne odporúčania.
ellaone
laboratoire hra pharma - ulipristal - antikoncepcia, postcoital - pohlavné hormóny a modulátory z genitálny systém , núdzovej antikoncepcie - núdzová antikoncepcia do 120 hodín (päť dní) nechráneného pohlavného styku alebo poruchy antikoncepcie.
eginilla
egis pharmaceuticals plc, maďarsko - ulipristal - 17 - anticoncipientia